Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

Show full item record



Permalink

http://hdl.handle.net/10138/325639

Citation

Witjes , J J , Smits , L P , Pekmez , C T , Prodan , A , Meijnikman , A S , Troelstra , M A , Bouter , K E C , Herrema , H , Levin , E , Holleboom , A G , Winkelmeijer , M , Beuers , U H , van Lienden , K , Aron-Wisnewky , J , Mannisto , V , Bergman , J J , Runge , J H , Nederveen , A J , Dragsted , L O , Konstanti , P , Zoetendal , E G , de Vos , W , Verheij , J , Groen , A K & Nieuwdorp , M 2020 , ' Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis ' , Hepatology communications , vol. 4 , no. 11 , pp. 1578-1590 . https://doi.org/10.1002/hep4.1601

Title: Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
Author: Witjes, Julia J.; Smits, Loek P.; Pekmez, Ceyda T.; Prodan, Andrei; Meijnikman, Abraham S.; Troelstra, Marian A.; Bouter, Kristien E. C.; Herrema, Hilde; Levin, Evgeni; Holleboom, Adriaan G.; Winkelmeijer, Maaike; Beuers, Ulrich H.; van Lienden, Krijn; Aron-Wisnewky, Judith; Mannisto, Ville; Bergman, Jacques J.; Runge, Jurgen H.; Nederveen, Aart J.; Dragsted, Lars O.; Konstanti, Prokopis; Zoetendal, Erwin G.; de Vos, Willem; Verheij, Joanne; Groen, Albert K.; Nieuwdorp, Max
Contributor: University of Helsinki, Department of Bacteriology and Immunology
Date: 2020-11
Language: eng
Number of pages: 13
Belongs to series: Hepatology communications
ISSN: 2471-254X
URI: http://hdl.handle.net/10138/325639
Abstract: The intestinal microbiota has been linked to the development and prevalence of steatohepatitis in humans. Interestingly, steatohepatitis is significantly lower in individuals taking a plant-based, low-animal-protein diet, which is thought to be mediated by gut microbiota. However, data on causality between these observations in humans is scarce. In this regard, fecal microbiota transplantation (FMT) using healthy donors is safe and is capable of changing microbial composition in human disease. We therefore performed a double-blind randomized controlled proof-of-principle study in which individuals with hepatic steatosis on ultrasound were randomized to two study arms: lean vegan donor (allogenic n = 10) or own (autologous n = 11) FMT. Both were performed three times at 8-week intervals. A liver biopsy was performed at baseline and after 24 weeks in every subject to determine histopathology (Nonalcoholic Steatohepatitis Clinical Research Network) classification and changes in hepatic gene expression based on RNA sequencing. Secondary outcome parameters were changes in intestinal microbiota composition and fasting plasma metabolomics. We observed a trend toward improved necro-inflammatory histology, and found significant changes in expression of hepatic genes involved in inflammation and lipid metabolism following allogenic FMT. Intestinal microbial community structure changed following allogenic FMT, which was associated with changes in plasma metabolites as well as markers of .Conclusion:Allogenic FMT using lean vegan donors in individuals with hepatic steatosis shows an effect on intestinal microbiota composition, which is associated with beneficial changes in plasma metabolites and markers of steatohepatitis.
Subject: FATTY LIVER-DISEASE
DNA
PROGRESSION
STABILITY
CAUSALITY
BACTERIAL
PROTECTS
SAMPLES
IMPACT
STAGE
3121 Internal medicine
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
hep4.1601.pdf 441.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record